glp-1 inflammation reduction Health Feed Do GLP-1 drugs reduce inflammation?
Description
Phase 2b/3 ongoing
Integrative Potential and Clinical Insight From a functional medicine perspective, GLP-1, GLP-2, and VIP peptides could become adjunctive supports in MCAS and related conditions such as IBS, POTS, EhlersDanlos syndrome, chronic fatigue, and long COVID, where mast-celldriven neuroinflammation plays a central role
Once cleared, Whitefish GLP-1 patients will receive a once-per-week injection
Photo by Innerbody Research Similar to Teeccino, Four Sigmatic doesnt make too many grand promises about its products, which is something we can appreciate
